Search

Author/Creator Lechowicz, Mary J.

1. A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T‐cell lymphoma (PTCL): final results from the T‐ cell consortium trial. (2nd December 2015)

Authors:
Advani, Ranjana H.; Ansell, Stephen M.; Lechowicz, Mary J.; Beaven, Anne W.; Loberiza, Fausto; Carson, Kenneth R.; Evens, Andrew M.; Foss, Francine; Horwitz, Steven; Pro, Barbara; Pinter‐Brown, Lauren C.; Smith, Sonali M.; Shustov, Andrei R.; Savage, Kerry J.; M. Vose, Julie
Journal:
British journal of haematology
Issue:
Volume 172:Number 4(2016)
Page Start:
535
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network. (19th April 2018)

Authors:
Federico, Massimo; Bellei, Monica; Marcheselli, Luigi; Schwartz, Marc; Manni, Martina; Tarantino, Vittoria; Pileri, Stefano; Ko, Young‐Hyeh; Cabrera, Maria E.; Horwitz, Steven; Kim, Won S.; Shustov, Andrei; Foss, Francine M.; Nagler, Arnon; Carson, Kenneth; Pinter‐Brown, Lauren C.; Montoto, Silvi...
Journal:
British journal of haematology
Issue:
Volume 181:Number 6(2018)
Page Start:
760
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗